Oncology Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/oncology/ The leading site for news and procurement in the pharmaceutical industry Wed, 21 Aug 2024 16:10:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Oncology Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/oncology/ 32 32 FDA declines to approve Regeneron’s linvoseltamab amid manufacturing issues https://www.pharmaceutical-technology.com/news/fda-declines-to-approve-regenerons-linvoseltamab-amid-manufacturing-issues/ Wed, 21 Aug 2024 16:09:52 +0000 https://www.pharmaceutical-technology.com/news/fda-declines-to-approve-regenerons-linvoseltamab-amid-manufacturing-issues/ Aadi axes 80% of staff after registrational Phase II trial fails https://www.pharmaceutical-technology.com/news/aadi-axes-80-of-staff-after-registrational-phase-ii-trial-fails/ Wed, 21 Aug 2024 14:40:14 +0000 https://www.pharmaceutical-technology.com/news/aadi-axes-80-of-staff-after-registrational-phase-ii-trial-fails/ Accenture invests in Earli to advance early cancer detection tech https://www.pharmaceutical-technology.com/news/accenture-earli-cancer-detection/ Tue, 20 Aug 2024 10:27:33 +0000 https://www.pharmaceutical-technology.com/news/accenture-earli-cancer-detection/ NMPA approves Astellas’ PADCEV for advanced urothelial cancer https://www.pharmaceutical-technology.com/news/nmpa-astellas-padcev-cancer/ Tue, 20 Aug 2024 08:29:27 +0000 https://www.pharmaceutical-technology.com/news/nmpa-astellas-padcev-cancer/ Daiichi Sankyo-AstraZeneca’s ENHERTU gains BTD for breast cancer https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazeneca-enhertu/ Mon, 19 Aug 2024 10:19:03 +0000 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazeneca-enhertu/ Armed with Phase III win, Incyte eyes label expansion for Monjuvi https://www.pharmaceutical-technology.com/news/armed-with-phase-iii-win-incyte-eyes-label-expansion-for-monjuvi/ Fri, 16 Aug 2024 13:47:50 +0000 https://www.pharmaceutical-technology.com/news/armed-with-phase-iii-win-incyte-eyes-label-expansion-for-monjuvi/ FDA accepts Deciphera’s vimseltinib NDA for priority review https://www.pharmaceutical-technology.com/news/fda-deciphera-vimseltinib-nda/ Fri, 16 Aug 2024 10:16:01 +0000 https://www.pharmaceutical-technology.com/news/fda-deciphera-vimseltinib-nda/ Nuntius partners with Taiho to develop mRNA cancer therapies https://www.pharmaceutical-technology.com/news/nuntius-partners-taiho-to-develop-mrna-cancer-therapies/ Fri, 16 Aug 2024 08:33:38 +0000 https://www.pharmaceutical-technology.com/news/nuntius-partners-taiho-to-develop-mrna-cancer-therapies/ AstraZeneca’s sBLA for LS-SCLC treatment gains FDA priority review https://www.pharmaceutical-technology.com/news/astrazenecas-sbla-imfinzi-gains-fda-priority-review/ Fri, 16 Aug 2024 08:27:20 +0000 https://www.pharmaceutical-technology.com/news/astrazenecas-sbla-imfinzi-gains-fda-priority-review/ NorthStar and Convergent expand deal for prostate cancer drug https://www.pharmaceutical-technology.com/news/northstar-convergent-expand-deal/ Wed, 14 Aug 2024 10:07:27 +0000 https://www.pharmaceutical-technology.com/news/northstar-convergent-expand-deal/